| Title : Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats - Gomaa_2023_Int.Immunopharmacol_117_109927 |
| Author(s) : Gomaa AA , Farghaly HSM , Ahmed AM , Hemida FK |
| Ref : Int Immunopharmacol , 117 :109927 , 2023 |
| Abstract : Gomaa_2023_Int.Immunopharmacol_117_109927 |
| ESTHER : Gomaa_2023_Int.Immunopharmacol_117_109927 |
| PubMedSearch : Gomaa_2023_Int.Immunopharmacol_117_109927 |
| PubMedID: 36848793 |
| Title : Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia - Gomaa_2022_Eur.J.Pharmacol__174873 |
| Author(s) : Gomaa AA , Farghaly HSM , Ahmed AM , El-Mokhtar MA , Hemida FK |
| Ref : European Journal of Pharmacology , :174873 , 2022 |
| Abstract : Gomaa_2022_Eur.J.Pharmacol__174873 |
| ESTHER : Gomaa_2022_Eur.J.Pharmacol__174873 |
| PubMedSearch : Gomaa_2022_Eur.J.Pharmacol__174873 |
| PubMedID: 35283111 |